ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 184 filers reported holding ACORDA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 4.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $23,475,000 | -13.8% | 1,248,655 | -4.3% | 0.00% | -25.0% |
| Q3 2016 | $27,238,000 | -17.6% | 1,304,487 | +0.6% | 0.00% | -20.0% |
| Q2 2016 | $33,063,000 | +2.7% | 1,296,325 | +6.5% | 0.01% | 0.0% |
| Q1 2016 | $32,194,000 | -34.3% | 1,217,174 | +6.2% | 0.01% | -37.5% |
| Q4 2015 | $49,023,000 | +61.8% | 1,145,944 | +0.2% | 0.01% | +60.0% |
| Q3 2015 | $30,305,000 | -22.2% | 1,143,170 | -2.2% | 0.01% | -16.7% |
| Q2 2015 | $38,967,000 | -3.0% | 1,169,134 | -3.2% | 0.01% | 0.0% |
| Q1 2015 | $40,181,000 | -16.8% | 1,207,374 | +2.2% | 0.01% | -25.0% |
| Q4 2014 | $48,295,000 | +19.5% | 1,181,666 | -1.0% | 0.01% | +14.3% |
| Q3 2014 | $40,428,000 | -2.6% | 1,193,265 | -3.1% | 0.01% | 0.0% |
| Q2 2014 | $41,516,000 | -8.9% | 1,231,570 | +2.4% | 0.01% | -12.5% |
| Q1 2014 | $45,578,000 | +3.7% | 1,202,262 | -20.1% | 0.01% | 0.0% |
| Q4 2013 | $43,949,000 | +12.9% | 1,505,115 | +32.2% | 0.01% | 0.0% |
| Q3 2013 | $38,940,000 | +1.9% | 1,138,611 | -1.7% | 0.01% | 0.0% |
| Q2 2013 | $38,216,000 | – | 1,158,406 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|